BHF Stock Analysis: Brighthouse Financial | NASDAQ
Insurance - Life | NASDAQ, USA | Market Cap: 2.524m USD | 12M Return: -35.8% | US10922N1037 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 35.6M
EPS Trend: 14.1%
Qual. Beats: 1
Rev. Trend: 73.9%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 9.3 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Brighthouse Financial, Inc. (BHF) is a U.S.-based insurer headquartered in Charlotte, North Carolina, that provides annuity and life insurance products through three segments: Annuities, Life, and Run-off. The Annuities segment offers variable, fixed, index-linked, and income annuities designed for tax-deferred wealth accumulation, wealth transfer, and income security. The Life segment sells term, universal, whole, and variable life insurance products, while the Run-off segment manages legacy blocks including universal life with secondary guarantees, structured settlements, pension risk transfer contracts, company-owned life insurance, and funding agreements.
The company was originally founded in 1863 and has been publicly traded since its 2017 IPO on NASDAQ. As a mid-cap stock in the GICS Life & Health Insurance sub-industry, Brighthouse operates within a sector characterized by liability-driven investment strategies, long-duration assets, and sensitivity to interest rate movements. Its spin-off origins from MetLife shape its product mix, which remains heavily weighted toward annuity solutions that compete with peers such as Athene, Corebridge, and Equitable in the retirement and protection market.
- Annuity sales growth driven by pension risk transfer demand
- Interest rate volatility impacts spread-based product margins
- Run-off segment capital release supports share buybacks
| Net Income: 682.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -0.68 > 1.0 |
| NWC/Revenue: 1.58k% < 20% (prev 472.1%; Δ 1.11k% < -1%) |
| CFO/TA -0.01 > 3% & CFO -1.49b > Net Income 682.0m |
| Net Debt (-5.37b) to EBITDA (908.0m): -5.92 < 3 |
| Current Ratio: 8.59k > 1.5 & < 3 |
| Outstanding Shares: last quarter (57.9m) vs 12m ago 0.26% < -2% |
| Gross Margin: 59.07% > 18% (prev 41.68%; Δ 17.39% > 0.5%) |
| Asset Turnover: 2.25% > 50% (prev 2.42%; Δ -0.17% > 0%) |
| Interest Coverage Ratio: 5.97 > 6 (EBIT TTM 908.0m / Interest Expense TTM 152.0m) |
| A: 0.36 (Total Current Assets 85.9b - Total Current Liabilities 10.0m) / Total Assets 239b |
| B: -0.00 (Retained Earnings -143.0m / Total Assets 239b) |
| C: 0.00 (EBIT TTM 908.0m / Avg Total Assets 241b) |
| D: 0.02 (Book Value of Equity 5.01b / Total Liabilities 234b) |
| Altman-Z'' = 2.41 = A |
As of November 18, 2026, the stock is trading at USD 42.16 with a total of 518,887 shares traded. Over the past week, the price has changed by -5.05%, over one month by -11.43%, over three months by -24.36% and over the past year by -35.75%.
Current recommended Stop Loss: 40.30 (which is 4.4% or 1.2 ATR below the current price).
Brighthouse Financial has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold BHF.
- StrongBuy: 0
- Buy: 0
- Hold: 7
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 57 | 35.2% |
P/E Trailing = 4.3978
P/E Forward = 3.3501
P/S = 0.4342
P/B = 0.5063
Revenue TTM = 5.43b USD
EBIT TTM = 908.0m USD
EBITDA TTM = 908.0m USD
Long Term Debt = 3.15b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 3.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -5.37b USD (calculated: Debt 3.15b - CCE 8.53b)
Enterprise Value = 2.52b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 5.97 (Ebit TTM 908.0m / Interest Expense TTM 152.0m)
EV/FCF = -1.69x (Enterprise Value 2.52b / FCF TTM -1.49b)
FCF Yield = -59.11% (FCF TTM -1.49b / Enterprise Value 2.52b)
FCF Margin = -27.48% (FCF TTM -1.49b / Revenue TTM 5.43b)
Net Margin = 12.56% (Net Income TTM 682.0m / Revenue TTM 5.43b)
Gross Margin = 59.07% ((Revenue TTM 5.43b - Cost of Revenue TTM 2.22b) / Revenue TTM)
Gross Margin QoQ = 65.18% (prev 63.56%)
Tobins Q-Ratio = 0.01 (Enterprise Value 2.52b / Total Assets 239b)
Interest Expense / Debt = 4.82% (Interest Expense 152.0m / Debt 3.15b)
Taxrate = 13.73% (109.0m / 794.0m)
NOPAT = 783.4m (EBIT 908.0m * (1 - 13.73%))
Current Ratio = 8.59k (out of range, set to none) (Total Current Assets 85.9b / Total Current Liabilities 10.0m)
Debt / Equity = 0.63 (Debt 3.15b / totalStockholderEquity, last quarter 5.01b)
Debt / EBITDA = -5.92 (Net Debt -5.37b / EBITDA 908.0m)
Debt / FCF = 3.60 (negative FCF - burning cash) (Net Debt -5.37b / FCF TTM -1.49b)
Total Stockholder Equity = 5.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.28% (Net Income 682.0m / Total Assets 239b)
RoE = 11.42% (Net Income TTM 682.0m / Total Stockholder Equity 5.97b)
RoCE = 9.95% (EBIT 908.0m / Capital Employed (Equity 5.97b + L.T.Debt 3.15b))
RoIC = 0.33% (NOPAT 783.4m / Invested Capital 238b)
WACC = 5.94% (E(2.52b)/V(5.68b) * Re(8.16%) + D(3.15b)/V(5.68b) * Rd(4.82%) * (1-Tc(0.14)))
Discount Rate = 8.16% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.88 | Cagr: -3.19%
[DCF] Fair Price = unknown (Cash Flow -1.49b)
EPS Correlation: 14.13 | EPS CAGR: 6.42% | SUE: 1.18 | # QB: 1
Revenue Correlation: 73.88 | Revenue CAGR: 24.46% | SUE: -0.94 | # QB: -1
EPS current Quarter (2027-03-31): EPS=5.22 | Chg30d=-0.26% | Revisions=-50% | Analysts=3
EPS current Year (2026-12-31): EPS=19.63 | Chg30d=+3.35% | Revisions=+0% | GrowthEPS=-29.7% | GrowthRev=-0.5%
EPS next Year (2027-12-31): EPS=19.60 | Chg30d=-2.43% | Revisions=-40% | GrowthEPS=-0.1% | GrowthRev=+1.4%
[Analyst] Revisions Ratio: -50% (up=1, down=6)